Atara Biotherapeutics, Inc. - 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of the 2019 Annual Meeting of Stockholders held by Atara Biotherapeutics, Inc. on June 27, 2019. The filing details the outcomes of four specific matters submitted to a vote by security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
The following matters were voted upon at the Annual Meeting:
- Election of Directors: Both nominees, Matthew K. Fust and Roy Baynes, were elected to serve until the 2022 annual meeting. Roy Baynes received significantly more "For" votes (38,664,800) compared to Matthew K. Fust (23,401,851), while Fust had a higher number of "Withheld" votes (16,297,067).
- Executive Compensation (Say-on-Pay): Stockholders approved the compensation of named executive officers on an advisory basis. The vote was 39,291,110 "For" versus 389,454 "Against".
- Frequency of Say-on-Pay Votes: Stockholders indicated a preference for annual advisory votes on executive compensation. The vote was 39,622,189 for "1 Year" versus 60,569 for "3 Years". The Company will hold such annual advisory votes until the next required frequency vote.
- Ratification of Auditors: Stockholders ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2019. The vote was 42,390,575 "For" versus 25,567 "Against".
Guidance, Outlook, and Risks
The filing does not contain management commentary on financial guidance, outlook, risks, contingencies, or unusual items. It strictly reports the procedural outcomes of the shareholder meeting.
Key Facts for Investor Verification
- Verify the specific reasons for the significant disparity in "Withheld" votes for director nominee Matthew K. Fust compared to Roy Baynes by reviewing the definitive proxy statement filed on April 30, 2019.
- Confirm the Company's commitment to holding annual say-on-pay votes as mandated by the shareholder preference expressed in this filing.
- Note that Deloitte & Touche LLP has been ratified as the auditor for the fiscal year ending December 31, 2019.